Correlates of broadly neutralizing antibody development

被引:8
|
作者
Abela, Irene A. [1 ]
Kadelka, Claus [2 ]
Trkola, Alexandra [1 ]
机构
[1] Univ Zurich, Inst Med Virol, Winterthurerstr 190, CH-8057 Zurich, Switzerland
[2] Iowa State Univ, Dept Math, Ames, IA USA
基金
瑞士国家科学基金会;
关键词
broadly neutralizing antibodies; HIV-1; vaccine; IMMUNODEFICIENCY-VIRUS TYPE-1; HIV-1; ANTIBODY; SPONTANEOUS CONTROLLERS; HUMORAL IMMUNITY; PASSIVE TRANSFER; INFECTION; BREADTH; RESPONSES; PROTECTION; PLASMA;
D O I
10.1097/COH.0000000000000552
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Purpose of review Broadly neutralizi"ng antibodies (bnAbs) are considered a key component of an effective HIV-1 vaccine, but despite intensive efforts, induction of bnAbs by vaccination has thus far not been possible. Potent bnAb activity is rare in natural infection and a deeper understanding of factors that promote or limit bnAb evolution is critical to guide bnAb vaccine development. This review reflects on recent key discoveries on correlates of bnAb development and discusses what further insights are needed to move forward. Recent findings An increasing number of parameters have been implicated to influence bnAb development in natural infection. Most recent findings highlight a range of immune factors linked with bnAb evolution. Novel approaches have brought exciting progress in defining signatures of the viral envelope associated with bnAb activity. Summary Focused efforts of recent years have unraveled a multiply layered process of HIV-1 bnAb development. As it is understood today, bnAb evolution can be triggered and influenced by a range of factors and several different pathways may exist how bnAb induction and maturation can occur. To capitalize on the gained knowledge, future research needs to validate factors to identify independent drivers of bnAb induction to advance vaccine design.
引用
收藏
页码:279 / 285
页数:7
相关论文
共 50 条
  • [1] Broadly Neutralizing Antibodies and the Development of Vaccines
    Haynes, Barton F.
    Bradley, Todd
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2015, 313 (24): : 2419 - 2420
  • [2] HIV broadly neutralizing antibody targets
    Wibmer, Constantinos Kurt
    Moore, Penny L.
    Morris, Lynn
    CURRENT OPINION IN HIV AND AIDS, 2015, 10 (03) : 135 - 143
  • [3] Determinants of HIV-1 broadly neutralizing antibody induction
    Rusert, Peter
    Kouyos, Roger D.
    Kadelka, Claus
    Ebner, Hanna
    Schanz, Merle
    Huber, Michael
    Braun, Dominique L.
    Hoze, Nathanael
    Scherrer, Alexandra
    Magnus, Carsten
    Weber, Jacqueline
    Uhr, Therese
    Cippa, Valentina
    Thorball, Christian W.
    Kuster, Herbert
    Cavassini, Matthias
    Bernasconi, Enos
    Hoffmann, Matthias
    Calmy, Alexandra
    Battegay, Manuel
    Rauch, Andri
    Yerly, Sabine
    Aubert, Vincent
    Klimkait, Thomas
    Boni, Jurg
    Fellay, Jacques
    Regoes, Roland R.
    Gunthard, Huldrych F.
    Trkola, Alexandra
    NATURE MEDICINE, 2016, 22 (11) : 1260 - 1267
  • [4] Development of an anti-HIV vaccine eliciting broadly neutralizing antibodies
    Ahmed, Yousuf
    Tian, Meijuan
    Gao, Yong
    AIDS RESEARCH AND THERAPY, 2017, 14
  • [5] Development of screening assays for use of broadly neutralizing antibodies in people with HIV
    Lynch, Rebecca M.
    Bar, Katharine J.
    CURRENT OPINION IN HIV AND AIDS, 2023, 18 (04) : 171 - 177
  • [6] Development of broadly neutralizing antibodies from autologous neutralizing antibody responses in HIV infection
    Derdeyn, Cynthia A.
    Moore, Penny L.
    Morris, Lynn
    CURRENT OPINION IN HIV AND AIDS, 2014, 9 (03) : 210 - 216
  • [7] COVID-19 antibody development fueled by HIV-1 broadly neutralizing antibody research
    Mendoza, Pilar
    Lorenzi, Julio C. C.
    Gaebler, Christian
    CURRENT OPINION IN HIV AND AIDS, 2021, 16 (01) : 25 - 35
  • [8] Virological features associated with the development of broadly neutralizing antibodies to HIV-1
    Moore, Penny L.
    Williamson, Carolyn
    Morris, Lynn
    TRENDS IN MICROBIOLOGY, 2015, 23 (04) : 204 - 211
  • [9] Broadly Neutralizing Antiviral Antibodies
    Corti, Davide
    Lanzavecchia, Antonio
    ANNUAL REVIEW OF IMMUNOLOGY, VOL 31, 2013, 31 : 705 - 742
  • [10] HIV-1 superinfection can occur in the presence of broadly neutralizing antibodies
    Serwanga, Jennifer
    Ssemwanga, Deogratius
    Muganga, Michael
    Nakiboneka, Ritah
    Nakubulwa, Susan
    Kiwuwa-Muyingo, Sylvia
    Morris, Lynn
    Redd, Andrew I.
    Quinn, Thomas C.
    Kaleebu, Pontiano
    VACCINE, 2018, 36 (04) : 578 - 586